Longeveron Announces Abstract Highlighting Data from Phase 1 Alzheimer's Disease Trial Accepted for Developing Topics Presentation at the 2021 Annual Alzheimer's Association International Conference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback